Dustin Aaron Silverman

Dr. Dustin Aaron Silverman

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SASukhkaran Singh Aulakh
Sukhkaran Singh Aulakh
DSDustin Aaron Silverman
Dustin Aaron Silverman
KYKurtis Young
Kurtis Young
SDSteven K. Dennis
Steven K. Dennis
ABAndrew Birkeland
Andrew Birkeland
As the seventh most common cancer globally, head and neck cancers (HNC) exert considerable disease burden, with an estimated 277,597 deaths worldwide in 2020 alone. Traditional risk factors for HNC include tobacco, alcohol, and betel nut; more recently, human papillomavirus has emerged as a distinct driver of disease. Currently, limitations of cancer screening and surveillance methods often lead to identifying HNC in more advanced stages, with associated poor outcomes. Liquid biopsies, in particular circulating tumor DNA (ctDNA), offer the potential for enhancing screening, early diagnosis, and surveillance in HNC patients, with potential improvements in HNC patient outcomes. In this review, we examine current methodologies for detecting ctDNA and highlight current research illustrating viral and non-viral ctDNA biomarker utilities in HNC screening, diagnosis, treatment response, and prognosis. We also summarize current challenges and future directions for ctDNA testing in HNC patients.

1 September 2021 in Otolaryngology Case Reports
Verified
Journal Article
Open access
DSDustin Aaron Silverman
Dustin Aaron Silverman
MLMichael M. Li
Michael M. Li
TOThomas E. Olencki
Thomas E. Olencki
NSNolan Seim
Nolan Seim
TTTheodoros N. Teknos
Theodoros N. Teknos
SKStephen Y. Kang
Stephen Y. Kang

3 April 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
SCSarah M. Chen
Sarah M. Chen
DSDustin Aaron Silverman
Dustin Aaron Silverman
KJKris R. Jatana
Kris R. Jatana
TCTendy Chiang
Tendy Chiang
TGTerri Guinipero
Terri Guinipero
SRSuzanne Reed
Suzanne Reed

1 April 2025 in OTO Open
Verified
Journal Article
Open access
SESoroush Ershadifar
Soroush Ershadifar
ACAngela Colback
Angela Colback
UBUgur Nur Basmaci
Ugur Nur Basmaci
MWMachelle Wilson
Machelle Wilson
ABAndrew C. Birkeland
Andrew C. Birkeland
DSDustin Aaron Silverman
Dustin Aaron Silverman
Objective: The fibula free flap (FFF) remains the workhorse flap for head and neck defects necessitating osteocutaneous reconstruction. Although lower extremity angiography, ultrasound (US), and other vascular studies are routinely used for fibula assessment and patient selection, predictors of donor‐site morbidity following harvest remain poorly understood. We sought to investigate the factors associated with FFF donor‐site complications.Study Design: Retrospective analysis of patients at a tertiary care center.Setting: Tertiary care center.Methods: In total, 119 patients undergoing FFF reconstruction during the years 2012 to 2022 were included. Multivariable logistic regression was used to identify independent predictors of soft‐tissue donor‐site wound complications.Results: A total of 48 (40.3%) patients developed a donor‐site wound complication with an average time to diagnosis of 24 days (±16) following surgery. In multivariable regression, history of alcohol use disorder (P = .0083) and method of donor‐site closure (P = .0368) were independent predictors of donor‐site wound complications. Split‐thickness skin graft closure was associated with a 146% increased odds of wound complications (odds ratio [OR] = 2.46, 1.11‐5.43, 95% confidence interval). Patient age, body mass index, Charlson comorbidity index, skin paddle size, and Doppler US characteristics were not predictive of postoperative donor‐site morbidity.Conclusion: Predictors of FFF donor‐site wound complications included history of alcohol abuse and method of donor‐site closure. This study highlights unique lower extremity Doppler US findings in patients undergoing FFF reconstruction in addition to modifiable risk factors associated with fibula donor‐site morbidity and soft‐tissue complications. Our findings underscore the need to critically evaluate wound closure techniques in this population.

29 October 2025
Verified
Book Chapter
Open access
PDF file
MMMallory McKeon
Mallory McKeon
MMMegha Mohanakrishnan
Megha Mohanakrishnan
PPPriscilla F.A. Pichardo
Priscilla F.A. Pichardo
ATAlice L. Tang
Alice L. Tang
CZChad A. Zender
Chad A. Zender
DSDustin Aaron Silverman
Dustin Aaron Silverman
Head and neck cancer is the sixth most common cancer worldwide with classically poor outcomes related to advanced disease at presentation. Despite improvements in treatment strategies, morbidity and mortality remain high among this patient population, with frequent disease recurrence and need for lifelong surveillance. Oropharyngeal squamous cell carcinoma (OPSCC), a disease historically associated with alcohol and tobacco abuse, has become increasingly prevalent in young, otherwise healthy patients related to chronic infection with human papillomavirus (HPV). Though this subset of patients has favorable response to therapy, patients’ young age and health status places them at higher risk for delayed diagnosis and represents a challenge for long-term cancer surveillance. Circulating tumor DNA (ctDNA) has recently gained traction as a potential surveillance tool and affords the opportunity to shift this paradigm. Herein, we delve into the current, though constantly evolving, knowledge surrounding ctDNA and its role in the management of patients with HPV-mediated squamous cell carcinoma of the head and neck.

25 November 2025 in Artificial Intelligence in Health
Verified
Journal Article
Open access
PDF file
DSDustin Aaron Silverman
Dustin Aaron Silverman
JHJohn S. Howard
John S. Howard
PPPriscilla F. A. Pichardo
Priscilla F. A. Pichardo
YPYash J. Patil
Yash J. Patil
MAMekibib Altaye
Mekibib Altaye
ATAlice L. Tang
Alice L. Tang
Artificial intelligence models such as chat generative pre-trained transformer (ChatGPT) are being increasingly used to inform treatment-related decisions. Among otolaryngology subspecialties, there is a paucity of literature examining the role of ChatGPT within head and neck surgical oncology. The utility of ChatGPT in addressing questions related to surgically relevant anatomy and lymphadenectomy procedures remains poorly understood. The primary pilot study objective was to determine the reliability of ChatGPT in answering neck dissection-related inquiries compared to expert head and neck surgical oncologists. Five neck dissection-related questions were presented to ChatGPT v3.5. Three fellowship-trained head and neck surgeons compared AI-generated responses to those of an expert head and neck surgeon. Raters, blinded to the author’s identity, evaluated the responses given based on a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The median level of agreement between raters for the ChatGPT responses was 1.0 (interquartile range [IQR]: 1.0, 2.5; minimum = 1 and maximum = 4), while the median level of agreement between raters for the surgeon responses was 5.0 (IQR: 5.0, 5.0; minimum = 5 and maximum = 5). The Mann–Whitney U test yielded a significance level of p=0.007 when comparing the level of agreement between ChatGPT and surgeon responses. Raters showed minimal consistency when evaluating ChatGPT responses (intraclass correlation coefficient = 0.05; 95% confidence interval: 0.0–0.88), in contrast to perfect agreement observed for the surgeon responses. In summary, ChatGPT is a promising tool in the acquisition of surgical knowledge. For neck dissection-related inquiries, a discrepancy between the reliability of ChatGPT-generated responses and surgeon expertise exists. Further refinement in AI models is needed to strengthen the utility of ChatGPT in head and neck oncologic surgery.